听力干预降低轻度认知障碍老年人痴呆风险:中国老年人认知改善听力解决方案(CHOICE)多中心随机对照试验研究方案
本研究为在中国上海四家研究中心开展的多中心平行组随机对照试验,计划纳入688例年龄≥60岁、诊断为中度至重度年龄相关听力损失(ARHL)合并轻度认知障碍(MCI)的老年人,随机分为助听器验配组与健康教育组,主要结局为两组进展为痴呆的比率,随访至干预后24个月。
要点
- ARHL被认定为可修饰的痴呆风险因素,MCI是正常认知向痴呆过渡的初始阶段。
- 研究纳入688例中度至重度ARHL合并MCI的老年人,随机分为助听器验配组与健康教育组。
- 主要结局为两组进展为痴呆的比率,在基线及干预后6、12、24个月进行评估。
核心结论
- 研究结果可能表明听力康复是管理ARHL和预防认知下降的有价值工具,有助于构建认知下降防控的综合框架。
研究设计与样本
- 多中心平行组随机对照试验,在中国上海四家研究中心开展。
- 计划纳入688例年龄≥60岁、诊断为中度至重度ARHL合并MCI的老年人。
- 采用区组随机化(区组大小不等)将参与者随机分配至助听器验配组或健康教育组。
- 由听力学家和经过培训的研究人员在基线及干预后6、12、24个月收集听力测定、认知功能评估等相关数据。
- 主要结局为两组参与者进展为痴呆的比率,并评估听力改善和认知功能变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 近年来缺乏探究助听器验配与认知功能改善之间可能因果关系的随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Age-related hearing loss (ARHL) signifies the bilateral, symmetrical, sensorineural hearing loss that commonly occurs in elderly individuals. Several studies have suggested a higher risk of dementia among patients diagnosed with ARHL. Although the precise causal association between ARHL and cognitive decline remains unclear, ARHL has been recognized as one of the most significant factors that can be modified to reduce the risk of developing dementia potentially. Mild cognitive impairment (MCI) typically serves as the initial stage in the transition from normal cognitive function to dementia. Consequently, the objective of our randomized controlled trial (RCT) is to further investigate whether the use of hearing aids can enhance cognitive function in older adults diagnosed with ARHL and MCI. METHODS AND DESIGN: This study is a parallel-arm, randomized controlled trial conducted at multiple centers in Shanghai, China. We aim to enlist a total of 688 older adults (age ≥ 60) diagnosed with moderate-to-severe ARHL and MCI from our four research centers. Participants will be assigned randomly to either the hearing aid fitting group or the health education group using block randomization with varying block sizes. Audiometry, cognitive function assessments, and other relevant data will be collected at baseline, as well as at 6, 12, and 24 months post-intervention by audiologists and trained researchers. The primary outcome of our study is the rate of progression to dementia among the two groups of participants. Additionally, various evaluations will be conducted to measure hearing improvement and changes in cognitive function. Apart from the final study results, we also plan to conduct an interim analysis using data from 12-month follow-up. DISCUSSION: In recent years, there has been a notable lack of randomized controlled trials (RCTs) investigating the possible causal relationship between hearing fitting and the improvement of cognitive function. Our findings may demonstrate that hearing rehabilitation can be a valuable tool in managing ARHL and preventing cognitive decline, which will contribute to the development of a comprehensive framework for the prevention and control of cognitive decline. TRIAL REGISTRATION: Chinese Clinical Trial Registry chictr.org.cn ChiCTR2000036139. Registered on 21 August 2020.
引用
- Chen Y, Guan L, Chen J, et al. Hearing intervention for decreasing risk of developing dementia in elders with mild cognitive impairment: study protocol of a multicenter randomized controlled trial for Chinese Hearing Solution for Improvement of Cognition in Elders (CHOICE). Trials. 2023. PMID: 38017543. doi:10.1186/s13063-023-07813-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。